Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results
- 30 November 2004
- journal article
- clinical trial
- Published by Elsevier in Digestive and Liver Disease
- Vol. 36 (11) , 752-759
- https://doi.org/10.1016/j.dld.2004.06.015
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Side effects of therapy for chronic hepatitis CGastroenterology, 2003
- Medicinal Herbs for Hepatitis C Virus Infection: A Cochrane Hepatobiliary Systematic Review of Randomized TrialsAmerican Journal of Gastroenterology, 2003
- Current therapy for hepatitis C: pegylated interferon and ribavirinClinics in Liver Disease, 2003
- Side effects of therapy of hepatitis C and their managementHepatology, 2002
- Role of hepatitis C infection in chronic liver disease in Egypt.The American Journal of Tropical Medicine and Hygiene, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Hepatitis C Virus InfectionNew England Journal of Medicine, 2001
- Clinical studies with silymarin: Fibrosis progression is the end pointHepatology, 2001
- The Use of Silymarin in the Treatment of Liver DiseasesDrugs, 2001
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998